Isogenic induced pluripotent stem cells (IPSCS) derived from mosaic hereditary hemorrhagic telangiectasia type 1 (HHT1) patient

V. V. Orlova, X. Cao, C. Freund, G. Sanchez-Duffhues, L. Hawinkels, S. Petrus-Reurer, F. E. van den Hil, F. Disch, R. J. Snijder, C. J. J. Westermann, J. J. Mager, P. ten Dijke, Ploos J. K. van Amstel, C. L. Mummery

Research output: Contribution to journalMeeting AbstractAcademic

Abstract

SESSION 12 MECHANISMS OF HHT
Original languageEnglish
Pages (from-to)129-129
JournalAngiogenesis
Volume21
Issue number1
DOIs
Publication statusPublished - 1 Feb 2018
Externally publishedYes

Cite this

Orlova, V. V. ; Cao, X. ; Freund, C. ; Sanchez-Duffhues, G. ; Hawinkels, L. ; Petrus-Reurer, S. ; van den Hil, F. E. ; Disch, F. ; Snijder, R. J. ; Westermann, C. J. J. ; Mager, J. J. ; ten Dijke, P. ; van Amstel, Ploos J. K. ; Mummery, C. L. / Isogenic induced pluripotent stem cells (IPSCS) derived from mosaic hereditary hemorrhagic telangiectasia type 1 (HHT1) patient. In: Angiogenesis. 2018 ; Vol. 21, No. 1. pp. 129-129.
@article{da2e3fd34f7040c9a0c918ed74260493,
title = "Isogenic induced pluripotent stem cells (IPSCS) derived from mosaic hereditary hemorrhagic telangiectasia type 1 (HHT1) patient",
abstract = "SESSION 12 MECHANISMS OF HHT",
author = "Orlova, {V. V.} and X. Cao and C. Freund and G. Sanchez-Duffhues and L. Hawinkels and S. Petrus-Reurer and {van den Hil}, {F. E.} and F. Disch and Snijder, {R. J.} and Westermann, {C. J. J.} and Mager, {J. J.} and {ten Dijke}, P. and {van Amstel}, {Ploos J. K.} and Mummery, {C. L.}",
year = "2018",
month = "2",
day = "1",
doi = "10.1007/s10456-017-9584-3",
language = "English",
volume = "21",
pages = "129--129",
journal = "Angiogenesis",
issn = "0969-6970",
publisher = "Springer",
number = "1",

}

Orlova, VV, Cao, X, Freund, C, Sanchez-Duffhues, G, Hawinkels, L, Petrus-Reurer, S, van den Hil, FE, Disch, F, Snijder, RJ, Westermann, CJJ, Mager, JJ, ten Dijke, P, van Amstel, PJK & Mummery, CL 2018, 'Isogenic induced pluripotent stem cells (IPSCS) derived from mosaic hereditary hemorrhagic telangiectasia type 1 (HHT1) patient' Angiogenesis, vol. 21, no. 1, pp. 129-129. https://doi.org/10.1007/s10456-017-9584-3

Isogenic induced pluripotent stem cells (IPSCS) derived from mosaic hereditary hemorrhagic telangiectasia type 1 (HHT1) patient. / Orlova, V. V.; Cao, X.; Freund, C.; Sanchez-Duffhues, G.; Hawinkels, L.; Petrus-Reurer, S.; van den Hil, F. E.; Disch, F.; Snijder, R. J.; Westermann, C. J. J.; Mager, J. J.; ten Dijke, P.; van Amstel, Ploos J. K.; Mummery, C. L.

In: Angiogenesis, Vol. 21, No. 1, 01.02.2018, p. 129-129.

Research output: Contribution to journalMeeting AbstractAcademic

TY - JOUR

T1 - Isogenic induced pluripotent stem cells (IPSCS) derived from mosaic hereditary hemorrhagic telangiectasia type 1 (HHT1) patient

AU - Orlova, V. V.

AU - Cao, X.

AU - Freund, C.

AU - Sanchez-Duffhues, G.

AU - Hawinkels, L.

AU - Petrus-Reurer, S.

AU - van den Hil, F. E.

AU - Disch, F.

AU - Snijder, R. J.

AU - Westermann, C. J. J.

AU - Mager, J. J.

AU - ten Dijke, P.

AU - van Amstel, Ploos J. K.

AU - Mummery, C. L.

PY - 2018/2/1

Y1 - 2018/2/1

N2 - SESSION 12 MECHANISMS OF HHT

AB - SESSION 12 MECHANISMS OF HHT

UR - http://www.scopus.com/inward/record.url?scp=85057556576&partnerID=8YFLogxK

U2 - 10.1007/s10456-017-9584-3

DO - 10.1007/s10456-017-9584-3

M3 - Meeting Abstract

VL - 21

SP - 129

EP - 129

JO - Angiogenesis

JF - Angiogenesis

SN - 0969-6970

IS - 1

ER -